Clinical trials recruiting in Würselen, Germany

Phase breakdown

Conditions recruiting in Würselen, Germany

Recruiting trials in Würselen, Germany

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
  NCT06868277 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• PROCARE - PROstate Cancer Real World Evidence Registry
  NCT06835218 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• Praegnant Breast Cancer: Early/Advanced/Metastatic
  NCT02338167 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis
  NCT06764706 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Würselen, Germany?

4 recruiting trials have at least one study site in Würselen, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.